We Are Owned by Pathologists

For over 25 years, we’ve been delivering results with precision, collaborating closely with referrers and advancing revolutionary technology. Today, we’re still owned and run by pathologists who put patients at the heart of every decision – all so we can improve diagnostic care for good.

Meet Our Pathologists

Dr. Chris Douglas

As medical director, Chris continues to ensure that Histopath provides an independent alternative to corporate medicine, focused on doctors, patients and staff rather than shareholder profit.

Dr Chris Douglas, pathologist founder of Histopath
Dr Chris Douglas
Director, MBBS Hons, FRCPA

Dr. Stephen Mann

Steve is co-director, co-owner and head pathologist of Histopath. His primary areas of interest and expertise are dermatopathology and gastrointestinal pathology, in which he continues to teach and have multiple publications.

Dr Stephen Mann, director and pathologist at Histopath
Dr Stephen Mann
Director, MBBS Hons, FRCPA, MACD

Dr. Sue Fredericks

Sue has been with Histopath since 2009 and has broad interests across the specialty of histopathology, particularly gastrointestinal, urological, head and neck pathology and dermatopathology.

Dr Sue Fredericks, pathologist at Histopath
Dr Sue Fredericks
MBBS, FRCPA

Dr. Hae Jin Jeong

Hae Jin has been with Histopath since 2012. She has a special interest and expertise in gastrointestinal pathology and medical parasitology. She also reports on many dermatopathology and uropathology cases daily.

Dr Hae Jin Jeong, pathologist at Histopath
Dr Hae Jin Jeong
MD, PhD, FRCPA, MIAC

Dr. Ranjalee Liyanasuriya

Ranjalee joined Histopath in 2012 with an interest in gastrointestinal, gynaecological, urological pathology and dermatopathology.

Dr Ranjalee Liyanasuriyalee, pathologist at Histopath
Dr Ranjalee
Liyanasuriya
MBBS, FRCPA, MD, DMJ

Dr. Melissa Holmes

Mel has been part of the Histopath team since 2017 and has a passionate interest and expertise in gynaecological, gastrointestinal, dermatological, urological and general surgical pathology.

Dr Melissa Holmes, pathologist at Histopath
Dr Melissa Holmes
BSc Med, MBBS, FRCPA

Dr. Ken Lai

To serve patients and clinicians more on a personal basis he has established and run his private histopathology practice for 27 years with emphasis on GIT and skin pathology. In 2017 his practice merged with Histopath based on similar values.

Dr Ken Lai, pathologist at Histopath
Dr Ken Lai
BSc Med, MBBS, FRCPA

Dr. Edward Roper

Ed is interested in all areas of Anatomical Pathology, with a particular focus on digital pathology, gastrointestinal and genitourinary pathology, and dermatopathology.

Dr Edward Roper, pathologist at Histopath
Dr Edward Roper
BA, MBBS (Hons), FRCPA

Dr. Andrew Gal

Andrew's main areas of practice are skin, urinary tract, gastrointestinal, oculoplastic and general surgicalpathology. He's developed a modified Moh’s type intra-operative frozen section diagnosis for plastic resection of complex cases of skin neoplasia.

Dr Andrew Gal, pathologist at Histopath
Dr Andrew Gal
BSc Med, MBBS, FRCPA

Dr. Amir Ashrafy

Amir is a general surgical pathologist with interest and expertise in gastrointestinal and medical liver pathology, pulmonary pathology and neuropathology.

Dr Amir Ashrafy, pathologist at Histopath
Dr Amir Ashrafy
MD, FRCPA

Dr. Raha Madadi Ghahan

Raha's areas of special interest within histopathology are within gastrointestinal, genitourinary and breast pathology.

Dr Raha Madadi Ghahan, pathologist at Histopath
Dr Raha Madadi
Ghahan
MD, FRCPA

Who We Are

Efficiency & Quality are at Our Core

Positioned at the forefront of histopathology advancements, we lead with innovation, pioneering routine digital pathology practices for faster turnaround times and seamless collaboration among our expert pathologists.

Combining human expertise with AI-powered tools, we set new standards for diagnostic precision, ultimately enhancing patient care. Our Lean workflow ensures streamlined processes, minimising errors and delivering prompt, accurate results without compromise.

Efficiency and quality are at our core, driving our commitment to diagnostic excellence. We stand as industry leaders, seamlessly integrating dedicated expertise with transformative technology.

Our Mission

How We Care

We understand the profound impact our work has on individuals and their families. We approach our responsibilities with the utmost compassion, professionalism and commitment to excellence.



Our mission is to provide accurate, timely and comprehensive histopathological services, supporting healthcare providers in diagnosing and treating a wide range of medical conditions.

We recognise that behind every specimen we analyse there is a patient and we embrace the responsibility that comes with it. Continuous learning, collaboration and rigorous safety and quality standards are integral to our mission, as we aim to provide the highest level of histopathological care, dedicated to our community's well-being.

From 1998 to today

Over 25 years we have grown into a laboratory we can be proud of. Still lead by our founding pathologist, we've achieved ground-breaking milestones towards better patient care.

1998

Histopath was founded by Dr. Chris Douglas and laboratory has become NATA Accredited.

2000

Dr. Stephen Mann joined Histopath as co-director.

2015

NATA accreditation and introduction of Intestinal Disaccharides testing in-house.

2016

Expansion and relocation to new site, custom built laboratory to adopt Lean Workflow. Laboratory has adopted a xylene-free workflow for better health and safety of our staff and the environment.

2019

Introduced AI to assist in the evaluation of prostate biopsies.

2020

NATA accreditation for Calprotectin testing, Helicobacter pylori testing on gastric biopsies and faecal specimens.

2020

Introduced PCR testing for COVID-19.

2021

NATA Accreditation of Airport laboratories for COVID-19 at Sydney, Melbourne, and Brisbane.

2021

Introducing 3D image scanners to Histopathology department.

2023

Academic collaboration with School of Medicine, Western Sydney University.

2023

Our laboratory has received Digital Pathology NATA Accreditation.

2024

First pathology in the APAC region to introduce automated tissue sectioning.

Be Part of Histopath's Future

We're pioneering advances in digital pathology and artificial intelligence, shaping a clearer future for patients, doctors and families.

Join our dedicated team of specialist pathologists, scientists, and innovators - all committed to delivering the best possible patient care.

Accreditation

  • We have been a NATA accredited laboratory since 1999, showcasing the advanced technical proficiency of our services.
  • We comply with the relevant National Pathology Accreditation Advisory Council (NPAAC) and ISO 15189 (2022) requirements.
  • We actively continue to participate in external Quality Assurance Programs of the Royal College of Pathologists (RCPA) and the College pf American Pathologists (CAP).
  • All our pathologists hold Fellowship of the The Royal College of Pathologists of Australasia (FRCPA) and actively participate in ongoing professional development.
  • We adhere to internal and external Quality Control programs with utmost care.

Hear from Our Founder

Dr. Chris Douglas, pathologist and director of Histopath

Dr. Chris Douglas

From the outset, our vision was clear: to create a histopathology practice that not only meets the highest standards of excellence, but also drives pioneering innovation in the field. Today, Histopath stands as a testament to our commitment to pushing the boundaries of what is possible in histopathology.


Our dedicated team of pathologists and scientists stand at the forefront of pioneering innovation. We bring an unwavering commitment to precision, accuracy and a deep understanding of the critical role they play in healthcare. But what truly sets us apart is our embrace of technology and innovation that has revolutionised the landscape of histopathology, allowing us to provide quicker, more accurate and more insightful diagnoses.



We recognise that challenges are opportunities for growth and innovation. Our ongoing investments in state-of-the-art technology and continuous education keep us at the forefront of our industry. We believe in collaborating closely with clinicians, researchers and hospitals to drive ground-breaking research initiatives. This collaborative spirit has led to the development of novel reporting techniques and a deeper understanding of diseases, ultimately benefiting patients and advancing the frontiers of medical knowledge.



We are deeply thankful to our patients and healthcare partners who trust us with their most critical diagnostic needs. Your support has been the driving force behind our success. We invite you to join us on this incredible journey.

Get in Touch

Got a question or an enquiry? 
We're here to help.

Contact Us